You can:
Name | Bombesin receptor subtype-3 |
---|---|
Species | Homo sapiens (Human) |
Gene | BRS3 |
Synonym | bombesin receptor subtype-3 BRS-3 bombesin like receptor 3 BB3 receptor bb3 |
Disease | Breast cancer Cancer |
Length | 399 |
Amino acid sequence | MAQRQPHSPNQTLISITNDTESSSSVVSNDNTNKGWSGDNSPGIEALCAIYITYAVIISVGILGNAILIKVFFKTKSMQTVPNIFITSLAFGDLLLLLTCVPVDATHYLAEGWLFGRIGCKVLSFIRLTSVGVSVFTLTILSADRYKAVVKPLERQPSNAILKTCVKAGCVWIVSMIFALPEAIFSNVYTFRDPNKNMTFESCTSYPVSKKLLQEIHSLLCFLVFYIIPLSIISVYYSLIARTLYKSTLNIPTEEQSHARKQIESRKRIARTVLVLVALFALCWLPNHLLYLYHSFTSQTYVDPSAMHFIFTIFSRVLAFSNSCVNPFALYWLSKSFQKHFKAQLFCCKAERPEPPVADTSLTTLAVMGTVPGTGSIQMSEISVTSFTGCSVKQAEDRF |
UniProt | P32247 |
Protein Data Bank | N/A |
GPCR-HGmod model | P32247 |
3D structure model | This predicted structure model is from GPCR-EXP P32247. |
BioLiP | N/A |
Therapeutic Target Database | T68887 |
ChEMBL | CHEMBL4080 |
IUPHAR | 40 |
DrugBank | N/A |
Name | DPhe6-Bn(1-13)NH2 |
---|---|
Molecular formula | C71H104N22O16 |
IUPAC name | (2S)-N-[(2S)-1-[[(2S)-1-[[2-[[(2R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanediamide |
Molecular weight | 1521.75 |
Hydrogen bond acceptor | 18 |
Hydrogen bond donor | 20 |
XlogP | -2.1 |
Synonyms | BDBM85479 |
Inchi Key | PENKJYXGHPFNSK-WZGJJMBXSA-N |
Inchi ID | InChI=1S/C71H104N22O16/c1-36(2)26-49(60(74)99)90-69(108)53(30-42-32-77-35-82-42)86-58(98)34-81-70(109)59(38(5)6)93-61(100)39(7)83-67(106)52(29-41-31-79-44-17-12-11-16-43(41)44)92-66(105)48(20-23-55(73)95)89-68(107)51(28-40-14-9-8-10-15-40)85-57(97)33-80-62(101)50(27-37(3)4)91-63(102)45(18-13-25-78-71(75)76)87-65(104)47(19-22-54(72)94)88-64(103)46-21-24-56(96)84-46/h8-12,14-17,31-32,35-39,45-53,59,79H,13,18-30,33-34H2,1-7H3,(H2,72,94)(H2,73,95)(H2,74,99)(H,77,82)(H,80,101)(H,81,109)(H,83,106)(H,84,96)(H,85,97)(H,86,98)(H,87,104)(H,88,103)(H,89,107)(H,90,108)(H,91,102)(H,92,105)(H,93,100)(H4,75,76,78)/t39-,45-,46-,47-,48-,49-,50-,51+,52-,53-,59-/m0/s1 |
PubChem CID | 91898965 |
ChEMBL | N/A |
IUPHAR | N/A |
BindingDB | 85479 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | <10000.0 nM | PMID10353842 | BindingDB |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218